Linkun Hu

752 total citations
37 papers, 538 citations indexed

About

Linkun Hu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Immunology. According to data from OpenAlex, Linkun Hu has authored 37 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 9 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Linkun Hu's work include Renal Transplantation Outcomes and Treatments (6 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and MRI in cancer diagnosis (4 papers). Linkun Hu is often cited by papers focused on Renal Transplantation Outcomes and Treatments (6 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and MRI in cancer diagnosis (4 papers). Linkun Hu collaborates with scholars based in China, United States and United Kingdom. Linkun Hu's co-authors include Cheng Chen, Cheng Yang, Jianquan Hou, Ruiming Rong, Tongyu Zhu, Ming Xu, Zhao Tian, Bin Yang, Sidong Xiong and Xuedong Wei and has published in prestigious journals such as The Journal of Urology, Frontiers in Immunology and Virology.

In The Last Decade

Linkun Hu

33 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linkun Hu China 14 168 129 109 105 89 37 538
Danuta Fedak Poland 15 140 0.8× 61 0.5× 84 0.8× 108 1.0× 106 1.2× 43 615
Julie Bellière France 16 228 1.4× 128 1.0× 110 1.0× 166 1.6× 159 1.8× 47 782
Ruoyun Tan China 15 256 1.5× 101 0.8× 76 0.7× 176 1.7× 156 1.8× 36 674
Marek Kuźniewski Poland 14 120 0.7× 108 0.8× 71 0.7× 164 1.6× 125 1.4× 65 538
Edith Bigot‐Corbel France 15 170 1.0× 56 0.4× 81 0.7× 87 0.8× 48 0.5× 54 575
Takeshi Fujita Japan 12 97 0.6× 68 0.5× 83 0.8× 74 0.7× 86 1.0× 47 421
Kinga Musiał Poland 13 117 0.7× 53 0.4× 64 0.6× 70 0.7× 208 2.3× 59 488
Kaiyin Wu Germany 17 121 0.7× 78 0.6× 209 1.9× 300 2.9× 190 2.1× 47 901
Gabriela Alperovich Spain 17 233 1.4× 95 0.7× 220 2.0× 209 2.0× 176 2.0× 35 925
Tamás Magyarlaki Hungary 14 111 0.7× 65 0.5× 162 1.5× 225 2.1× 72 0.8× 45 709

Countries citing papers authored by Linkun Hu

Since Specialization
Citations

This map shows the geographic impact of Linkun Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linkun Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linkun Hu more than expected).

Fields of papers citing papers by Linkun Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linkun Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linkun Hu. The network helps show where Linkun Hu may publish in the future.

Co-authorship network of co-authors of Linkun Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Linkun Hu. A scholar is included among the top collaborators of Linkun Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linkun Hu. Linkun Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ye, Xin, Zheng Zhou, Linkun Hu, et al.. (2025). Metagenomic Next-Generation Sequencing-Assisted Risk Prediction and Stratification of Infections After Kidney Transplantation: A Case Study of COVID-19. Infection and Drug Resistance. Volume 18. 4763–4776.
3.
Zhang, Yan, Ling Xue, Linkun Hu, et al.. (2025). Exploring the comprehensive factors influencing tacrolimus pharmacokinetics in early renal transplant recipients: A population pharmacokinetic analysis. European Journal of Clinical Pharmacology. 81(5). 785–799.
4.
Ma, Jin, Jie Li, Jiali Ma, et al.. (2025). Magnetic resonance diffusion tensor imaging is superior to arterial spin labeling in detecting renal allograft fibrosis. Quantitative Imaging in Medicine and Surgery. 15(4). 3211–3221. 1 indexed citations
6.
Jiang, Bin, Yixing Yu, Rui Xu, et al.. (2023). The Use of Diffusion Tensor Imaging in the Identification of Acute Rejection and Chronic Allograft Nephropathy After Renal Transplantation. Journal of Magnetic Resonance Imaging. 59(6). 2082–2088. 2 indexed citations
7.
Lin, Yuxin, Liangliang Wang, Hui Yu, et al.. (2021). Multi-omics network characterization reveals novel microRNA biomarkers and mechanisms for diagnosis and subtyping of kidney transplant rejection. Journal of Translational Medicine. 19(1). 346–346. 9 indexed citations
8.
Yang, Cheng, Linkun Hu, Zheng Wei, et al.. (2020). Tolerance induction with donor hematopoietic stem cell infusion in kidney transplantation: a single-center experience in China with a 10-year follow-up. Annals of Translational Medicine. 8(21). 1378–1378. 2 indexed citations
9.
Li, Feng, Bo Li, Yuhua Huang, et al.. (2020). Resection of adult polycystic kidney with retroperitoneal laparoscopic technique assisted by arterial embolization. Translational Andrology and Urology. 9(6). 2705–2712. 1 indexed citations
10.
Ju, Jie, Zili Zhang, Cong Zhao, et al.. (2019). Discovery of potent necroptosis inhibitors targeting RIPK1 kinase activity for the treatment of inflammatory disorder and cancer metastasis. Cell Death and Disease. 10(7). 77 indexed citations
11.
Li, Feng, Linkun Hu, Xiao‐Jun Zhao, et al.. (2019). The value of cystatin C and urinary and serum neutrophil gelatinase-associated lipocalin during the perioperative period of renal transplantation. Translational Andrology and Urology. 8(5). 432–441. 6 indexed citations
12.
Cheng, Chen, Jie Shen, Zhaoyu Xing, et al.. (2019). Significance of examined lymph-node count in accurate staging and long-term survival in patients undergoing radical prostatectomy: a population-based study. International Urology and Nephrology. 52(2). 271–278. 2 indexed citations
14.
Xu, Renfang, et al.. (2018). The performance of the new prognostic grade and stage groups in conservatively treated prostate cancer. Asian Journal of Andrology. 20(4). 366–366. 2 indexed citations
15.
Hu, Linkun, et al.. (2017). IL-35 Pretreatment Alleviates Lipopolysaccharide-Induced Acute Kidney Injury in Mice by Inhibiting NF-κB Activation. Inflammation. 40(4). 1393–1400. 22 indexed citations
16.
Zhang, Xuefeng, Linkun Hu, Xuedong Wei, et al.. (2017). Eukaryotic Elongation Factor 2 (eEF2) is a Potential Biomarker of Prostate Cancer. Pathology & Oncology Research. 24(4). 885–890. 10 indexed citations
17.
Zhang, Jun, Linkun Hu, Cong Li, et al.. (2016). Clinical features of renal epithelioid angiomyolipoma. Zhonghua miniao waike zazhi. 37(6). 420–422.
18.
Zhao, Xiaojun, et al.. (2012). Randomized prospective trial of tubeless versus conventional minimally invasive percutaneous nephrolithotomy. World Journal of Urology. 31(5). 1303–1307. 25 indexed citations
19.
Hu, Linkun, Cheng Yang, Zhao Tian, et al.. (2011). Erythropoietin Ameliorates Renal Ischemia and Reperfusion Injury via Inhibiting Tubulointerstitial Inflammation. Journal of Surgical Research. 176(1). 260–266. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026